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Abstract	
Objective:	to	study	the	relationship	between	neonatal	morbidity	(NNM)and	two–years	
neurodevelopmental	impairment	(NDI)	in	surviving	children	after	early	fetal	growth	restriction	(FGR).	
Design:	Secondary	analyses	of	an	European	randomized	trial	(	TRUFFLE)	of	delivery	for	very	preterm	
fetuses	dependent	on	venous	Doppler	or	cardiotocographic	criteria	
Setting:	Tertiary	perinatal	centres,	participants	in	TRUFFLE	
Population:	402	surviving	children	after	early	FGR.	
Methods:	Prospective	data	were	collection	from	the	recognition	of	FGR	until	the	corrected	age	two	years.	
We	studied	the	association	between	NNM	and	NDI,	retaining	trial	allocation	in	all	statistical	models.	NNM	
included	any	of	bronchopulmonary	dysplasia,	brain	injury,	sepsis	or	necrotising	enterocolitis.	NDI	was	a	
composite	of	Bayley	cognitive	score	<85,	cerebral	palsy	or	severe	sensory	impairment.	
Main	Outcome	Measure:	NDI	in	relation	to	NNM.	
Results:	NNM	occurred	in	104	cases	(26%	of	402)	and	was	more	frequent	in	17	of	39		infants	(44%)	with	
NDI	than	in	the	87	of	363	infants	(24%)	with	normal	outcome	(OR	2.5	(1.3	to	4.8;	p=0.01).		In	22	of	39	NDI	
cases	(56%)	there	was	no	preceding	NNM.		NNM	was	inversely	related	to	gestational	age.		NDI	did	not	vary	
by	gestational	age.	In	multivariable	analyses,	cerebral	ultrasound	abnormalities	were	most	strongly	
associated	with	NDI,	together	with	trial	group	allocation,	birth	weight	ratio	(BWR),	infant		sex	and	Apgar	
score.	
Conclusions:	With	the	exception	of	cerebral	ultrasound	abnormalities,	commonly	used	neonatal	
morbidities	are	poor	markers	of	later	neurodevelopmental	impairment	and	should	not	be	used	as	
surrogate	outcomes	for	NDI.	
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Introduction	
Perinatal	researchers	often	use	neonatal	morbidities	as	surrogate	outcomes	for	longer-term	childhood	
outcomes	in	studies	of	early	(intra-uterine)	exposures	or	interventions	(1,2).	There	is	evidence	that	specific	
neonatal	morbidities,	such	as	focal	brain	injury	detected	with	ultrasound,	bronchopulmonary	dysplasia,	
neonatal	sepsis	and	retinopathy	are	risk	factors	for	later	development.	The	causal	pathways	for	these	
associations	may	involve	structural	injury	or	more	subtle	white	matter	damage,	through	interruption	of	
oligodendrocyte	maturation,	for	example	by	sepsis	(3).		However	these	associations	are	imprecise,	perhaps	
because	early	alterations	in	brain	maturation	during	fetal	life,	socio-demographic	characteristics,	and	other	
environmental	and	family	factors,	mediate	much	of	the	longer	term	outcome	(4,5,6).		This	might	be	
particularly	true	in	babies	with	preterm	fetal	growth	restriction	(FGR),	as	this	condition	alone	may	be	the	
main	risk	factor	for	NDI,	through	associated	alterations	in	brain	maturation	(7,8,9).	
In	FGR	pregnancies,		prolonging	pregnancy	may	lead	to	fetal	death	or	fetal	brain	injury,	due	to	fetal	
hypoxia	or	prolonged	malnutrition.	Delivering	too	early	may	lead	to	neonatal	death	due	to	prematurity	or	
to	brain	injury	caused	by	related	neonatal	morbidities.	Thus,	the	relative	role	of	neonatal	morbidity	may	be	
less	important	in	determining	survival	without	neurodevelopmental	impairment	following	FGR.	
TRUFFLE	(the	Trial	of	Randomised	Fetal	Flow	Velocities	in	Europe)	investigated	whether	ductus	venosus	
(DV)	measurement	changes	(as	either	early	or	late	(absent	A-wave)	changes)	combined	with	
cardiotocography	(CTG)	used	as	a	trigger	for	delivery,	could	increase	the	chance	of	healthy	outcomes	
compared	to	reduced	short	term	variation	of	fetal	heart	rate	in	pregnancies	complicated	by	FGR	between	
26	and	32	weeks	(10).	The	primary	outcome	was	defined	as	survival	without	neurodevelopmental	
impairment	(NDI)	at	2	years	of	age	corrected	for	preterm	birth.	A	composite	of	neonatal	morbidities	was	a	
secondary	outcome	and	did	not	differ	between	study	groups.	In	contrast,	the	use	of	DV	measures	was	
associated	with	increased	proportions	of	babies	surviving	free	of	NDI.		
In	this	secondary	analyses	we	aimed	to	explore	the	relation	between	neonatal	morbidity	and	survival	with	
and	without	NDI	at	2	years	of	age.	In	addition,	because	neonatal	morbidity	is	strongly	associated	to	
gestational	age	(1),	and	severity	of	fetal	growth	restriction	(11)	we	aimed	to	explore	whether	neonatal	
morbidity	and	NDI	are	associated	similarly	across	gestational	age	and	birthweight	ratio	subgroups.	Finally	
we	aimed	to	explore		which	prenatal	and	delivery	factors,	apart		from	neonatal		risk	factors	are	associated	
with	NDI.	
Methods	
The	design	and	principal	outcomes	for	TRUFFLE	have	been	described	previously	(10,12).	In	short,	women	
with	singleton	fetuses	at	26-32	weeks	of	gestation,	with	fetal	abdominal	circumference	<10th	percentile,	
estimated	fetal	weight	≥	500	g	and	umbilical	artery	Doppler	pulsatility	index	(PI)	>95th	percentile,	were	
included	in	a	twenty	centre	European	study	(ISRCTN	56204499).	Baseline	maternal	and	fetal	data	were	
collected	via	a	secure	internet	data	entry	page.	Study	group	allocation	was	performed	in	an	even	ratio	
from	randomly	sized	blocks,	stratified	for	gestational	age	(lower	or	higher	than	29	weeks	of	gestation)	and	
for	participating	centres.	Eligible	women	were	randomly	allocated	for	delivery	according	to	one	of	three	
monitoring	arms:	reduced	cardiotocography	(CTG)	fetal	heart	rate	short-term	variation	(STV<3.5	ms	at	a	
gestational	age	below	29	weeks	and	<4.0	ms	thereafter);	early	ductus	venosus	changes	(PI>95th	percentile;	
‘DV	p95’);	or	late	ductus	venosus	changes	(‘a’	wave	at	or	below	baseline;	‘DV	no	A’).	Abnormal	DV	
measurements	had	to	be	repeated	within	24	hours,	if	permitted	by	other	measures	of	fetal	condition,	to	
demonstrate	that	this	was	a	consistent	observation.	In	all	groups	delivery	could	also	be	decided	on	‘safety	
net	criteria’	when	the	CTG	showed	recurrent	decelerations,	or	in	the	DV	groups	when	STV	was	very	low	
(STV<2.6	ms	at	a	gestational	age	below	29	weeks	and	<3.0	ms	thereafter).		
Gestational	age	was	calculated	using	a	first	trimester	dating	ultrasound	scan	or,	in	the	absence	of	an	early	
scan,	from	the	date	of	the	last	menstrual	period	if	supported	by	later	ultrasound	findings.		
The	ratio	of	birth	weight	to	the	median	(50th	percentile)	weight	for	gestational	age,	adjusted	for	maternal	
ethnicity,	weight	and	length	and	infant	sex,	was	calculated	as	a	measure	of	the	severity	of	FGR	(BWR,	birth	
weight	ratio)	following	Gardosi	(13).		A	BWR	of	0.86	is	comparable	to	P10		and	a	BWR	of	0.68	to	P2.3	on	a	
birth	weight		curve.			
Severe	neonatal	morbidity	(NNM)	was	registered	as	a	composite	of	one	or	more	of	the	following	severe	
morbidities:	bronchopulmonary	dysplasia	(BPD),	severe	germinal	matrix	cerebral	haemorrhage	[GMH;	
intra-ventricular	hemorrhage	with	dilation	of	the	lateral	ventricles	(grade	3)	or	intra-parenchymal	
hemorrhage	(grade	4)],	cystic	periventricular	leucomalacia	(PVL),	proven	neonatal	sepsis	(positive	blood	
culture	requiring	treatment	with	antibiotics),	necrotizing	enterocolitis	(NEC;	Bell’s	stage	2	or	greater:	
presence	of	pneumatosis	or	perforation	on	x-ray	or	identified	by	laparotomy)	and	bronchopulmonary	
dysplasia	(BPD;	defined	as	receiving	supplemental	oxygen	at	36	weeks	postmenstrual	age).	Neonatal	data	
were	extracted	from	clinical	records	and	entered	directly	into	the	website	study	database.	
Surviving	children	and	their	parents	were	invited	to	the	follow-up	clinics	in	each	of	the	participating	
institutions.	Development	was	assessed	using	the	Bayley-III	Scales	of	Infant	and	Toddler	Development	(14).	
The	cognitive	outcome	is	reported	as	the	composite	cognitive	scale	with	a	normed	mean	of	100	and	a	SD	
of	15.	For	some	children	only	the	second	edition	of	the	Bayley	Scales	was	available.		To	compensate	for	
discrepancies	between	editions	of	the	Bayley	Scales	(15),	five	points	were	added	to	Bayley	II	Mental	
developmental	index	(MDI)	scores.			If	no	Bayley	test	could	be	performed	because	of	impairments,	the	
attending	paediatrician	was	asked	to	assess	an	estimate	of	cognitive	delay	(no	delay,	3-6	months	or	more	
than	6	months	delay).		
All	assessed	children	had	a	formal	neurological	examination	to	determine	the	presence	of	cerebral	palsy	
(CP),	which	was	classified	using	the	Surveillance	of	Cerebral	Palsy	in	Europe	(SCPE)	classification.	The	
functional	severity	of	CP	was	scored	using	the	Gross	Motor	Function	Classification	System	(GMFCS).	
Neurodevelopmental	impairment	(NDI)	was	defined	as	a	Cognitive	Bayley	III	score	or	corrected	Bayley	II	
MDI	of	<85	or	an	estimated	cognitive	delay	>3	months,	CP	with	a	GMFCS	>1,	hearing	loss	requiring	hearing	
aids	or	severe	visual	loss	(legally	certifiable	as	blind	or	partially	sighted).	
Differences	between	groups	were	compared	using	ANOVA,	Pearson’s	Chi-square	or	Fisher	exact	tests	as	
appropriate.		To	analyse	the	impact	of	neonatal	morbidity,	odds	ratios	and	confidence	intervals	were	
calculated	for	neurodevelopmental	impairment	(NDI)	and	constituent	disabilities.		The	group	of	402	infants	
were	subsequently	divided	into	five	gestational	age	groups	(26-27,	28-29,	30-31,	32-33,	>=34)	and	6	BWR	
groups	(<0.40,	0.4-	,	0.5-,	0.6-,	0.7,	and	≥0.8);	the	relation	between	gestational	age	and	BWR	groups,	and	
the	proportions	with	NNM	and	NDI	were	analyzed.	
Multivariable	logistic	regression	analysis	was	used	to	assess	the	association	between	a	range	of	factors	and	
outcomes.	Odds	ratios	(OR),	with	95	percent	confidence	limits	(95%CI),	were	calculated.	We	use	a	
dichotomous	dependent	variable	(NDI	versus	no	NDI)	and	included	independent	factors	that	were	
significantly	associated	with	two	years	outcomes	in	univariate	analysis.	Study	group	was	forced	into	in	the	
final	model.		
	IBM	SPSS	version	22	(New	York,	USA)	was	used	for	statistical	calculations.	
	 	
	Results		
Among	the	503	births	to	women	entered	into	TRUFFLE,	41	babies	died	before	2	years	of	age,	neonatal	
information	of	one	baby	was	unavailable	and	we	excluded	59	children	who	were	not	examined	at	two	
years,	leaving	402/461	(87%)	survivors	for	this	analysis	(see	our	earlier	publication	(10)	for	flowchart).	The	
children	included	were	representative	of	the	whole	cohort	(Table	1)	over	a	range	of	factors.	Ninety	two	
percent	of	the	Truffle	cohort	received	antenatal	corticosteroids.		We	have	no	data	on	placental	
microscopy.	However,	99%	of	all	liveborn	infants	were	delivered	by	caesarean	section	before	the	onset	of	
labour,	which	makes	chorioamnionitis	unlikely.	There	were	no	differences	in	demographic,	obstetric	or	
neonatal	variables	between	the	randomised	fetal	monitoring	groups	and	between	infants	with	or	without	
follow-up	at	2	years	(Data	were	shown	in	our	earlier	paper	(10))		
Consistent	with	the	main	trial	findings	(10),	among	the	402	included	children	who	survived	and	were	
examined	at	2	years	of	age,	there	was	a	trend	in	the	proportion	without	NDI	across	the	three	trial	groups,	
being	highest	in	the	DVnoA	and	lowest	in	the	STV	groups	(p=.02).		
NNM	was	more	common	among	those	with	NDI	(24%	v	44%;	OR	2.5	;	95%	CI	1.3	to	4.8;	p=0.01),	however,	
in	22	of	39	infants	with	NDI	there	was	no	preceding	neonatal	morbidity	(56%;	95%	CI	41%	to	72%.)		(Table	
2).	For	NNM	to	predict		NDI,	sensitivity	was	44%	and	specificity	was	76%.	Among	individual	morbidities	
there	were	significantly	higher	rates	of	NDI	among	those	with	abnormal	cerebral	ultrasound	(OR:	8.8;	95%	
CI	2.5	to	30.2)	and	bronchopulmonary	dysplasia	(OR:	2.7;	95%	CI	1.1	to	6.3).		Rates	of	sepsis	were	not	
significantly	higher	in	those	with	NDI	(OR:	1.7;	95%CI	0.8	to	3.7).	There	were	a	number	of	other	factors	that	
increased	the	risk	of	NDI,	including	male	sex,	exposure	to	maternal	smoking,	those	with	a	Apgar	score	<7,	
and	with	lower	BWR	values	(all	p<.05).	The	gestational	age	distribution	did	not	differ	across	the	two	groups	
with	and	without	NDI.		
Among	those	with	NNM	only	16%	had	NDI	compared	to	7%	among	those	without	(OR:	2.5	(1.3,	4.8);	table	
3).	The	positive	predictive	value		thus	was	16%,	and	negative	predictive	value	93%.	Cerebral	palsy	was	
more	frequent	following	NNM	(OR:	6.1	(1.8,	20.8))	but	other	components	of	NDI	did	not	differ	statistically	
between	those	with	or	without	NNM.	This	high	OR	should	be	placed	in	proper	perspective	given	that	there	
were	only	6	infants	total	out	of	402	with	CP	for	what	is	overall	a	very	low	rate	of102%	of	CP	in	the	study	
cohort.	
The	proportion	with	NNM	falls	rapidly	from	68%	at	26-27	weeks	of	gestation	to	11%	at	34	weeks	or	greater	
(p<.001).	There	is	a	non	significant	reduction	in	NDI	from	16%	at	26-27w	to	8%	at	>34w	(p=.40;	Figure	1a).	
Similarly,	the	proportion	with	NDI	falls	from	17%	at	BWR	<0.4	to	9%	at	BWR	≥0.8	(p=0.06)	but	there	is	no	
relationship	between	BWR	and	NNM	(p	0.98;	Figure	1b).		
We	used	stepwise	multivariable	analysis	to	explore	the	relationship	between	NDI	and	those	factors	
significantly	associated	with	outcome	on	univariable	analysis	(Table	2),	including	trial	allocation	with	CTG-
STV	allocation	as	the	reference	group.	In	the	final	model,	6	factors	were	independently	associated	with	NDI	
at	2	years	Cerebral	ultrasound	abnormality	was	the	strongest	negative	associate	(OR:	19.0;	95%	CI	4.2	to	
85.2)	but	was	only	present	in	3%	of	the	population,	contributing	15%	of	the	variance	in	2-year	outcomes.	In	
male	infants	and	infants	with	Apgar	scores	<7	and	a	lower	BWR,	NDI	was	also	seen	more	frequently.		
Allocation	to	each	DV	monitoring	group	as	part	of	the	trial	was	associated	with	a	lower	frequency	of	NDI.	A	
receiver	operating	characteristic	curve	(ROC)	analysis	had	an	area	under	the	curve	of	0.78	for	the	final	
model,	consistent	with	a	poor	prediction.		
	 	
	Discussion	
Main	findings.	
In	surviving	preterm	infants	born	after	severe	fetal	growth	restriction	the	risk	for	neurological	impairment	
was	increased	by	the	presence	of	severe	neonatal	morbidity	(OR	2.5;	95%	CI	1.3	to	4.8)	but	for	56%	(95%	CI	
41%-72%)	infants	with	NDI,	neurodevelopmental	impairment	was	not	preceded	by	any	of	the	components	
of	our	neonatal	morbidity	composite.	Whilst	the	presence	of	neonatal	morbidity	was	strongly	associated	
with	gestational	age	at	birth,	the	proportion	with	NDI	did	not	differ	significantly	over	the	gestation	range.	
In	contrast,	the	relationship	of	BWR	was	clearer	for	NDI	than	for	NNM.	Multivariable	analysis	identified	key	
protective	factors,	including	the	study	allocation	to	the	two	DV	monitoring	arms,	and	one	major	neonatal	
risk	factor.	We	thus	demonstrate	that	in	preterm	babies	born	after	FGR	composite	neonatal	morbidity	
appears	a	poor	proxy	outcome	for	NDI-free	survival.		
Strengths	of	this	study	were	the	large	prospective	sample	of	children	born	after	fetal	growth	restriction,	
born	in	several	European	countries.	Also,	the	use	of	BWR,	rather	than	a	cut-off	of	<p5	or	<p10	for	
birthweight,	provided	further	insight	in	the	degree	of	FGR	and	it’s	relation	to	both	NNM	and	NDI.		
Limitations	were	the	loss	to	follow	up	of	13%,	that	was	not	related	to	GA,	BWR	or	NNM.	NDI	occurred	in	a	
rather	low	rate	of	10%,	therefore	further	explorations	of	associations	of	pregnancy,	delivery		and	neonatal	
morbidities	(the	last	aim	of	this	paper)	lacked	power.	
Interpretation.Current	perinatal	practice	is	to	delay	the	delivery	of	very	preterm	fetuses	with	growth	
restriction	to	a	later	gestational	age.(7)	However	delaying	delivery	does	require	close	monitoring	of	the	
fetus	as	increasing	the	degree	of	growth	restriction	(reducing	the	BWR)	is	also	associated	with	adverse	
outcome.	Preterm	birth	is	associated	with	reduced	overall	and	regional	brain	volumes.	Using	magnetic	
resonance	imaging	(MRI),	babies	born	after	preterm	FGR	had	lower	brain	volumes	shortly	after	birth	and	at	
term-term	equivalent	age	compared	to	normally	grown	preterm	infants.(16)	This	deficit	comprised	mainly	
of	reduced	grey	matter	volumes,	with	a	lesser	effect	on	the	white	matter.	A	further	study	in	very	low	birth	
weight	infants	found	an	association	of	fetal	Doppler	indices	and	2-year	development	and	suggested	that	
this	association	was	mediated	through	lower	brain	volume,	which	they	measured	at	term-equivalent	age	
using	MRI	(5).	However,	the	effect	of	the	severity	of	FGR	(as	expressed	by	BWR)	on	brain	volumes	in	
prospectively	followed	fetuses	was	not	evaluated,	but	a	progressive	effect	on	brain	growth	seems	
plausible.	Thus	timing	of	delivery	balances	between	the	risk	for	neonatal	morbidity	by	earlier	delivery	and	
NDI	with	increasing	FGR	by	later	delivery.	Additionally	we	have	confirmed	in	this	multivariable	analysis,	
that	using	either	of	the	two	ductus	venosus	monitoring	strategies	in	TRUFFLE	is	associated	with	reduced	
long-term	morbidity	compared	to	a	reliance	on	STV	on	cardiotocography.	
This	study	intended	to	investigate	whether	there	was	a	strong	relationship	between	NNM	and	NDI.	We	did	
not	this	strong	relationship.	Moreover,	of	all	the	components	of	NNM,	in	our	multivariate	analysis,	only	
cerebral	ultrasound	abnormalities	were	kept	into	the	model	and	were	significantly	associated	with	NDI.	
Cerebral	ultrasound	abnormalities	are	most	frequent	in	the	most	preterm	fetuses	and	probably	a	
consequence	of	neonatal	immaturity.		However,	this	study	was	not	designed	to	demonstrate	increased	risk	
of	major	GMH	or	PVL	associated	with	FGR.	Strategies	that	prevent	brain	injury	would	be	by	preventing	
fetal	and	perinatal	acidosis	or	swings	in	cerebral	blood	pressure	before	delivery	(17,18).	It	is	worth	noting	
that	most	cerebral	ultrasound	abnormalities	occurred	in	the	DV	groups	(4.2%	in	combined	DV	groups	vs	
0.6%	STV	group;	P<0.05),(9)	but	this	may	simply	reflect	improved	survival	at	low	gestational	ages.	
We	here	demonstrate	a	larger	vulnerability	for	males	(OR	0.87	(0.77	to	0.98))	for	NDI.	In	literature	on	
outcomes	after	FGR		sex	differences	are	hardly	reported		(19).	In	4	year	old	children	born	FGR	after	early-
onset	hypertensive	pregnancy	complications,	abnormal	neurodevelopmental	outcomes	was	also	
associated	with	male	sex	(20).	
In	this	study		a	rather	low	rate	if	NDI	is	found.	Because	of	inconsistencies	in	defining	FGR	in	literature	and	
differentiation	from	small	for	gestational	age	(SGA),		comparing		our	NDI	rate	to	other	studies	is	
challenging	(19)	.	Previously	we	suggested	that	a	conservative	approach	to	timing	delivery	in	waiting	for	
late	ductus	venosus	changes—unless	severe	CTG	changes	defined	as	safetynet	occur	first—was	associated	
with	a	more	favourable	2	year	(10).	However,	the	age	of	two	is	rather	early	in	child	development	and	
further	follow	up,	probably	at	least	until	school	age	(20,21,	22,),	would	provide	extra	insight	into	the	
consequences	of	FGR	and	interventions	that	influence	timing	of	delivery,	because	cognitive	development,	
together	with	other	measures	of	neuropsychiatric	functioning	can	better	be	assessed	at	that	age,	with	less	
emphasis	on	motor	and	social	development.		
Conclusion	
Although,	in	FGR-infants,	the	presence	of	neonatal	morbidity	is	highly	associated	with	impairment	at	2	
years	it	appears	to	be	a	poor	proxy	for	‘NDI’	as	a	primary	outcome,	as	the	majority	of	those	with	NDI	have	
no	neonatal	morbidity.		Considering	individual	neonatal	morbidities,	the	predictive	value	is	best	for	
cerebral	ultrasound	abnormalities,	which	are	relatively	infrequent	compared	to	NDI.		Until	better	short	
term	markers	of	long	term	neurodevelopmental	impairment	are	identified,	perinatal	studies	with	
important	neurological	outcomes	should	plan	2-year	outcome	evaluations	at	the	very	least.	
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Legend	to	figure	1a	
Barplot	describing	rates	of	NNM	and	NDI	over		gestational	age	(GA)	groups.	Total	numbers	of	each	
gestational	group	are	presented	above	the	bars.	There	was	a	significant	relation	between	NNM	and	GA	
(p<0.001)	,	but	not	between	NDI	and	GA	(p=0.40).	
	
	
Legend	to	figure	1b	
Barplot	describing	rates	of	NNM	and	NDI	over		birth	weight	ratio	(BWR)	groups.	Total	numbers	of	each	
BWR	group	are	presented	above	the	bars.	There	was	no	significant	relation	between	NNM	and	BWR	
(p=0.98)	,	and		between	NDI	and	BWR	(p=0.06).	
	
	 	
	
